Article

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

2009-09-21

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d14dbb22-18cf-5ed2-9fa2-1259a0062681
DOI: 10.1083/jcb1866oia11

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosisDOI 10.1083/jcb1866oia11Read

Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic CellsSemantic proximity Read

SOCS3 and its role in associated diseasesSemantic proximity Read

SOCS, Inflammation, and AutoimmunitySemantic proximity Read

SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?Semantic proximity Read

SOCS3Semantic proximity Read

Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice--brief report.Semantic proximity Read

Identification of SOCS-3 as a Potential Mediator of Central Leptin ResistanceSemantic proximity Read

Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis.Semantic proximity Read

SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related CancerSemantic proximity Read

Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1Semantic proximity Read

SOCS1: a potent and multifaceted regulator of cytokines and cell‐mediated inflammationSemantic proximity Read

SOCS, inflammation, and cancerSemantic proximity Read